NCT03240731 - HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

April 8, 2024

Study Completion Date

April 8, 2024

Conditions

Sickle Cell Disease

Interventions

BIOLOGICAL

bone marrow transplant

haploidentical bone marrow transplant

Trial Locations (7)

CHU Henri-Mondor, Créteil

intercommunal hospital of Créteil, Créteil

CHU La Timone, Marseille

Hospital Necker, Paris

Hospital Robert-Debré, Paris

Saint-Louis hospital, Paris

CHU Strasbourg, Strasbourg